Bio-Sig-Logo-horiz.jpg
BioSig Appoints John W. Osborn, Ph.D. as Consultant on Autonomic Neuromodulation
04 mars 2020 07h52 HE | BioSig Technologies, Inc.
Westport, CT, March 04, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig to Webcast its Presentation at the Cowen and Company’s 40th Annual Health Care Conference
03 mars 2020 12h20 HE | BioSig Technologies, Inc.
Westport, CT, March 03, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at the Cowen & Co. 40th Annual Health Care
26 févr. 2020 08h33 HE | BioSig Technologies, Inc.
Westport, CT, Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Closing of Public Offering of Common Stock
25 févr. 2020 15h25 HE | BioSig Technologies, Inc.
Westport, CT, Feb. 25, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Announces $10 Million Public Offering of Common Stock
21 févr. 2020 08h45 HE | BioSig Technologies, Inc.
Westport, CT, Feb. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Proposed Public Offering of Common Stock
20 févr. 2020 16h18 HE | BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
PURE EP(TM) System
BioSig Completes 100th Patient Case with PURE EP(TM) System
19 févr. 2020 08h33 HE | BioSig Technologies, Inc.
WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Commercialization and install plan ahead of scheduleInstallations at new centers are driving patient enrollments and clinical data collection BioSig...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at the 25th Annual International AF Symposium
21 janv. 2020 07h52 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig to Commence Patient Cases at Mayo Clinic
16 janv. 2020 07h52 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 16, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Awarded Additional US Patent Claims for its PURE EP(TM) System
14 janv. 2020 07h52 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Company allowed a fifth utility patent Claims address methods for removing voltage offset from biomedical signalsEleven additional patent applications...